LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Lapatinib | 10 | uM | LJP6 | 2 | M19 | 72 | hr | 1334 | 3613 | 3899 | 0.9266 | 0.9038 |
BT-20 | Lapatinib | 10 | uM | LJP6 | 3 | M19 | 72 | hr | 1334 | 3586 | 3921 | 0.9145 | 0.8883 |
BT-20 | Sirolimus | 0.04 | uM | LJP6 | 1 | L18 | 72 | hr | 1334 | 2420 | 3955 | 0.6118 | 0.4618 |
BT-20 | Sirolimus | 0.04 | uM | LJP6 | 2 | L18 | 72 | hr | 1334 | 2631 | 3899 | 0.6748 | 0.5508 |
BT-20 | Sirolimus | 0.04 | uM | LJP6 | 3 | L18 | 72 | hr | 1334 | 2515 | 3921 | 0.6414 | 0.5030 |
BT-20 | Sirolimus | 0.12 | uM | LJP6 | 1 | L17 | 72 | hr | 1334 | 2297 | 3955 | 0.5807 | 0.4139 |
BT-20 | Sirolimus | 0.12 | uM | LJP6 | 2 | L17 | 72 | hr | 1334 | 2466 | 3899 | 0.6325 | 0.4872 |
BT-20 | Sirolimus | 0.12 | uM | LJP6 | 3 | L17 | 72 | hr | 1334 | 2474 | 3921 | 0.6309 | 0.4872 |
BT-20 | Sirolimus | 0.37 | uM | LJP6 | 1 | L16 | 72 | hr | 1334 | 2373 | 3955 | 0.5999 | 0.4436 |
BT-20 | Sirolimus | 0.37 | uM | LJP6 | 2 | L16 | 72 | hr | 1334 | 2643 | 3899 | 0.6778 | 0.5554 |
BT-20 | Sirolimus | 0.37 | uM | LJP6 | 3 | L16 | 72 | hr | 1334 | 2457 | 3921 | 0.6266 | 0.4807 |
BT-20 | Sirolimus | 1.11 | uM | LJP6 | 1 | L15 | 72 | hr | 1334 | 2424 | 3955 | 0.6128 | 0.4633 |
BT-20 | Sirolimus | 1.11 | uM | LJP6 | 2 | L15 | 72 | hr | 1334 | 2508 | 3899 | 0.6432 | 0.5036 |
BT-20 | Sirolimus | 1.11 | uM | LJP6 | 3 | L15 | 72 | hr | 1334 | 2446 | 3921 | 0.6238 | 0.4764 |
BT-20 | Sirolimus | 3.33 | uM | LJP6 | 1 | L14 | 72 | hr | 1334 | 2398 | 3955 | 0.6062 | 0.4533 |
BT-20 | Sirolimus | 3.33 | uM | LJP6 | 2 | L14 | 72 | hr | 1334 | 2462 | 3899 | 0.6314 | 0.4857 |
BT-20 | Sirolimus | 3.33 | uM | LJP6 | 3 | L14 | 72 | hr | 1334 | 2485 | 3921 | 0.6337 | 0.4915 |
BT-20 | Sirolimus | 10 | uM | LJP6 | 1 | L13 | 72 | hr | 1334 | 2790 | 3955 | 0.7053 | 0.6007 |
BT-20 | Sirolimus | 10 | uM | LJP6 | 2 | L13 | 72 | hr | 1334 | 2758 | 3899 | 0.7073 | 0.5988 |
BT-20 | Sirolimus | 10 | uM | LJP6 | 3 | L13 | 72 | hr | 1334 | 2698 | 3921 | 0.6880 | 0.5725 |
BT-20 | ZSTK474 | 0.04 | uM | LJP6 | 1 | M18 | 72 | hr | 1334 | 4328 | 3955 | 1.0941 | 1.1181 |
BT-20 | ZSTK474 | 0.04 | uM | LJP6 | 2 | M18 | 72 | hr | 1334 | 3535 | 3899 | 0.9066 | 0.8772 |
BT-20 | ZSTK474 | 0.04 | uM | LJP6 | 3 | M18 | 72 | hr | 1334 | 3672 | 3921 | 0.9364 | 0.9173 |
BT-20 | ZSTK474 | 0.12 | uM | LJP6 | 1 | M17 | 72 | hr | 1334 | 4099 | 3955 | 1.0362 | 1.0459 |
BT-20 | ZSTK474 | 0.12 | uM | LJP6 | 2 | M17 | 72 | hr | 1334 | 3840 | 3899 | 0.9848 | 0.9803 |